Literature DB >> 29507955

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.

Masaru Miura1,2, Tohru Kobayashi3, Tetsuji Kaneko2, Mamoru Ayusawa4, Ryuji Fukazawa5, Naoya Fukushima1, Shigeto Fuse6, Kenji Hamaoka7, Keiichi Hirono8, Taichi Kato9, Yoshihide Mitani10, Seiichi Sato11, Shinya Shimoyama12, Junko Shiono13, Kenji Suda14, Hiroshi Suzuki15, Jun Maeda16, Kenji Waki17, Hitoshi Kato3, Tsutomu Saji18, Hiroyuki Yamagishi16, Aya Ozeki2, Masako Tomotsune2, Makiko Yoshida2, Yohei Akazawa19, Kentaro Aso20, Shouzaburoh Doi21, Yoshi Fukasawa9, Kenji Furuno22, Yasunobu Hayabuchi23, Miyuki Hayashi5, Takafumi Honda24, Norihisa Horita25, Kazuyuki Ikeda7, Masahiro Ishii26, Satoru Iwashima27, Masahiro Kamada28, Masahide Kaneko3, Hiroshi Katyama29, Yoichi Kawamura30, Atushi Kitagawa26, Akiko Komori4, Kenji Kuraishi31, Hiroshi Masuda3, Shinichi Matsuda32, Satoshi Matsuzaki19, Sayaka Mii33, Tomoyuki Miyamoto34, Yuji Moritou28, Noriko Motoki19, Kiyoshi Nagumo35, Tsuneyuki Nakamura36, Eiki Nishihara31, Yuichi Nomura37, Shohei Ogata26, Hiroyuki Ohashi10, Kenichi Okumura29, Daisuke Omori38, Tetsuya Sano39, Eisuke Suganuma32, Tsutomu Takahashi40, Shinichi Takatsuki18, Atsuhito Takeda41, Masaru Terai24, Manatomo Toyono42, Kenichi Watanabe15, Makoto Watanabe5, Masaki Yamamoto43, Kenichiro Yamamura44.   

Abstract

Importance: Few studies with sufficient statistical power have shown the association of the z score of the coronary arterial internal diameter with coronary events (CE) in patients with Kawasaki disease (KD) with coronary artery aneurysms (CAA). Objective: To clarify the association of the z score with time-dependent CE occurrence in patients with KD with CAA. Design, Setting, and Participants: This multicenter, collaborative retrospective cohort study of 44 participating institutions included 1006 patients with KD younger than 19 years who received a coronary angiography between 1992 and 2011. Main Outcomes and Measures: The time-dependent occurrence of CE, including thrombosis, stenosis, obstruction, acute ischemic events, and coronary interventions, was analyzed for small (z score, <5), medium (z score, ≥5 to <10; actual internal diameter, <8 mm), and large (z score, ≥10 or ≥8 mm) CAA by the Kaplan-Meier method. The Cox proportional hazard regression model was used to identify risk factors for CE after adjusting for age, sex, size, morphology, number of CAA, resistance to initial intravenous immunoglobulin (IVIG) therapy, and antithrombotic medications.
Results: Of 1006 patients, 714 (71%) were male, 341 (34%) received a diagnosis before age 1 year, 501 (50%) received a diagnosis between age 1 and 5 years, and 157 (16%) received a diagnosis at age 5 years or older. The 10-year event-free survival rate for CE was 100%, 94%, and 52% in men (P < .001) and 100%, 100%, and 75% in women (P < .001) for small, medium, and large CAA, respectively. The CE-free rate was 100%, 96%, and 79% in patients who were not resistant to IVIG therapy (P < .001) and 100%, 96%, and 51% in patients who were resistant to IVIG therapy (P < .001), respectively. Cox regression analysis revealed that large CAA (hazard ratio, 8.9; 95% CI, 5.1-15.4), male sex (hazard ratio, 2.8; 95% CI, 1.7-4.8), and resistance to IVIG therapy (hazard ratio, 2.2; 95% CI, 1.4-3.6) were significantly associated with CE. Conclusions and Relevance: Classification using the internal diameter z score is useful for assessing the severity of CAA in relation to the time-dependent occurrence of CE and associated factors in patients with KD. Careful management of CE is necessary for all patients with KD with CAA, especially men and IVIG-resistant patients with a large CAA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29507955      PMCID: PMC5875323          DOI: 10.1001/jamapediatrics.2018.0030

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  17 in total

1.  Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.

Authors:  Lori Mosca; Elizabeth Barrett-Connor; Nanette Kass Wenger
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations.

Authors:  Takashi Ohkubo; Ryuji Fukazawa; Ei Ikegami; Shunichi Ogawa
Journal:  Pediatr Int       Date:  2007-02       Impact factor: 1.524

3.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

4.  Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture.

Authors:  E Barrett-Connor
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

5.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.

Authors: 
Journal:  Circ J       Date:  2014-09-22       Impact factor: 2.993

6.  Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).

Authors: 
Journal:  Pediatr Int       Date:  2014-04       Impact factor: 1.524

7.  A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population.

Authors:  Tohru Kobayashi; Shigeto Fuse; Naoko Sakamoto; Masashi Mikami; Shunichi Ogawa; Kenji Hamaoka; Yoshio Arakaki; Tsuneyuki Nakamura; Hiroyuki Nagasawa; Taichi Kato; Toshiaki Jibiki; Satoru Iwashima; Masaru Yamakawa; Takashi Ohkubo; Shinya Shimoyama; Kentaro Aso; Seiichi Sato; Tsutomu Saji
Journal:  J Am Soc Echocardiogr       Date:  2016-06-07       Impact factor: 5.251

Review 8.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

9.  Aneurysms of the coronary arteries in Kawasaki disease. An angiographic study of 30 cases.

Authors:  Z Onouchi; S Shimazu; N Kiyosawa; T Takamatsu; K Hamaoka
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

10.  Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.

Authors:  Shohei Ogata; Adriana H Tremoulet; Yuichiro Sato; Kayla Ueda; Chisato Shimizu; Xiaoying Sun; Sonia Jain; Laura Silverstein; Annette L Baker; Noboru Tanaka; Yoshihito Ogihara; Satoshi Ikehara; Shinichi Takatsuki; Naoko Sakamoto; Tohru Kobayashi; Shigeto Fuse; Tomoyo Matsubara; Masahiro Ishii; Tsutomu Saji; Jane W Newburger; Jane C Burns
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

View more
  15 in total

1.  Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.

Authors:  Michael A Portman; Nagib S Dahdah; April Slee; Aaron K Olson; Nadine F Choueiter; Brian D Soriano; Sujatha Buddhe; Carolyn A Altman
Journal:  Pediatrics       Date:  2019-05-02       Impact factor: 7.124

2.  Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms.

Authors:  Laura Gellis; Daniel A Castellanos; Rebecca Oduor; Kimberlee Gauvreau; Audrey Dionne; Jane Newburger; Kevin G Friedman
Journal:  J Cardiovasc Comput Tomogr       Date:  2021-09-16

3.  Health care utilization and costs following Kawasaki disease.

Authors:  Cal Robinson; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Hsien Seow; Michelle Batthish
Journal:  Paediatr Child Health       Date:  2022-03-01       Impact factor: 2.600

4.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

Review 5.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 6.  Lifetime cardiovascular management of patients with previous Kawasaki disease.

Authors:  Paul Brogan; Jane C Burns; Jacqueline Cornish; Vinod Diwakar; Despina Eleftheriou; John B Gordon; Huon Hamilton Gray; Thomas William Johnson; Michael Levin; Iqbal Malik; Philip MacCarthy; Rachael McCormack; Owen Miller; Robert M R Tulloh
Journal:  Heart       Date:  2019-12-16       Impact factor: 5.994

7.  Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease.

Authors:  Shinsuke Hoshino; Sonia Jain; Chisato Shimizu; Samantha Roberts; Feng He; Lori B Daniels; Andrew M Kahn; Adriana H Tremoulet; John B Gordon; Jane C Burns
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-01

8.  Serial Exercise Testing and Echocardiography Findings of Patients With Kawasaki Disease.

Authors:  Ko-Long Lin; I-Hsiu Liou; Guan-Bo Chen; Shu-Fen Sun; Ken-Pen Weng; Chien-Hui Li; Sheng-Hui Tuan
Journal:  Front Pediatr       Date:  2022-03-23       Impact factor: 3.418

9.  Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Gang Wu; Peng Yue; Fan Ma; Yi Zhang; Xiaolan Zheng; Yifei Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

10.  Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.

Authors:  Xuting Zhang; Yuee He; Yiping Shao; Biyao Hang; Zhipeng Xu; Maoping Chu
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-26       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.